These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32020439)

  • 21. Signal Detection of Potential Hepatotoxic Drugs: Case-Control Study Using Both a Spontaneous Reporting System and Electronic Medical Records.
    Akimoto H; Nagashima T; Minagawa K; Hayakawa T; Takahashi Y; Asai S
    Biol Pharm Bull; 2021; 44(10):1514-1523. PubMed ID: 34602560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disproportionality Analysis of Stomatitis Associated with Anticancer Drugs Using the Japanese Adverse Drug Event Report Database.
    Hosonaka K; Yamaoka K; Ikeda N; Uchida M; Uesawa Y; Takahashi K; Shimizu T
    Oncology; 2024; 102(9):810-818. PubMed ID: 38198784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase®.
    Matlala MF; Lubbe MS; Steyn H
    Afr J Prim Health Care Fam Med; 2023 Jan; 15(1):e1-e9. PubMed ID: 36744452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database.
    Hasegawa S; Ikesue H; Nakao S; Shimada K; Mukai R; Tanaka M; Matsumoto K; Inoue M; Satake R; Yoshida Y; Goto F; Hashida T; Nakamura M
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1279-1294. PubMed ID: 32869941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of completeness for spontaneous reporting of disease-modifying therapies in multiple sclerosis.
    Araujo AGS; Lucchetta RC; Tonin FS; Pontarolo R; Borba HHL; Wiens A
    Expert Opin Drug Saf; 2021 Jun; 20(6):735-740. PubMed ID: 33641547
    [No Abstract]   [Full Text] [Related]  

  • 26. [Assessment of the Relationship between Hypnotics and Delirium Using the Japanese Adverse Drug Event Report (JADER) Database].
    Kikuchi N; Hazama K; Imai T; Suzuki S; Yoshida Y; Hidaka S
    Yakugaku Zasshi; 2018; 138(7):985-990. PubMed ID: 29962478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database.
    Sato K; Mano T; Iwata A; Toda T
    J Neurooncol; 2019 Oct; 145(1):1-9. PubMed ID: 31452071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.
    Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B
    Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Influence of the Rapid Increase in the Number of Adverse Event Reports for COVID-19 Vaccine on the Disproportionality Analysis Using JADER.
    Yamaoka K; Fujiwara M; Uchida M; Uesawa Y; Shimizu T
    In Vivo; 2023; 37(1):345-356. PubMed ID: 36593055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review.
    Ohta M
    Eur J Clin Pharmacol; 2021 Oct; 77(10):1443-1452. PubMed ID: 33829295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stress cardiomyopathy (Takotsubo syndrome) in patients who received adrenergic agonist drugs: A pharmacovigilance study using the Japanese Adverse Drug Event Report (JADER) database.
    Sato K; Iwata A; Kurihara M; Mano T; Toda T
    J Cardiol; 2022 Jan; 79(1):36-41. PubMed ID: 34493421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting System.
    Suzuki S; Imai S; Mitsuboshi S; Kizaki H; Hashiguchi M; Hori S
    J Clin Pharmacol; 2023 Aug; 63(8):903-908. PubMed ID: 37042319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
    Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
    Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
    J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Data-Driven Identification of Factors That Influence the Quality of Adverse Event Reports: 15-Year Interpretable Machine Learning and Time-Series Analyses of VigiBase and QUEST.
    Choo SM; Sartori D; Lee SC; Yang HC; Syed-Abdul S
    JMIR Med Inform; 2024 Apr; 12():e49643. PubMed ID: 38568722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse Cutaneous Drug Reactions Associated with Old- and New- Generation Antiepileptic Drugs Using the Japanese Pharmacovigilance Database.
    Hosohata K; Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K
    Clin Drug Investig; 2019 Apr; 39(4):363-368. PubMed ID: 30689189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analyses of Ocular Adverse Reactions Associated With Anticancer Drugs Based on the Japanese Pharmacovigilance Database.
    Tanaka J; Koseki T; Kondo M; Ito Y; Yamada S
    Anticancer Res; 2022 Sep; 42(9):4439-4451. PubMed ID: 36039456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association Analysis.
    Fujiwara M; Kawasaki Y; Yamada H
    PLoS One; 2016; 11(4):e0154425. PubMed ID: 27119382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria.
    Elemuwa UG; Bitrus F; Oreagba IA; Osakwe AI; Abiodun AS; Onu K; Abubakar A; Faniyi AE; Etuk V; Yuah D; Momodu R; Adeyeye CM
    Pharmaceut Med; 2024 May; 38(3):251-259. PubMed ID: 38705932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First experiences with a tool to measure the level of clinical information present in adverse drug reaction reports.
    Oosterhuis I; Rolfes L; Ekhart C; Muller-Hansma A; Härmark L
    Expert Opin Drug Saf; 2018 Feb; 17(2):111-115. PubMed ID: 29157026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.